Kalinova Radostina G, Dimitrov Ivaylo V, Ilieva Yana, Iliev Dimitar B, Miloshev George A, Staneva Dessislava N, Zaharieva Maya M, Nesheva Aleksandrina, Staneva Galya, Ivanova Diana I, Angelov George, Najdenski Hristo M
Institute of Polymers, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
National Centre of Excellence "Mechatronics and Clean Technologies", 8 Kliment Ohridski Blvd, 1756 Sofia, Bulgaria.
Int J Mol Sci. 2025 May 28;26(11):5167. doi: 10.3390/ijms26115167.
Nanotechnology offers alternative approaches to the discovery of anticancer drugs. Hydrophobic bioactive components can be included in the cores of amphiphilic nanocarriers, which leads to the formation of a water-dispersible product with improved bioavailability, facilitated excretion, and reduced systemic toxicity in the treated organisms. This study was aimed at the formation of polymer nanocarriers, loaded with anticancer drug precursor podophylotoxin (PPT) or PPT-containing juniper leaf extracts, seeking to study their antineoplastic activity in A-431 epidermoid carcinoma cells and HaCaT normal keratinocytes. The amphiphilic, biodegradable, and biocompatible MPEG--PLA diblock copolymer was self-assembled in aqueous media into nanosized particles, whose physicochemical characteristics were studied by dynamic light scattering, transmission electron microscopy, and other methods. High encapsulation efficiency was determined for the PPT component-loaded micelles. DNA fragmentation, cell cycle arrest, nuclear condensation, membrane lipid order assessment, reactive oxygen species, and apoptosis induction by the loaded nanocarriers in A-431 or HaCaT cells were analyzed by the comet assay, FACS, Hoechst DNA staining, Laurdan generalized polarization, and other methods. As a result of various cellular processes induced by the PPT component-loaded nanoparticles, effector caspase-3 and caspase-7 activation showed selectivity towards tumor cells compared to the normal cells. The newly obtained PPT-containing nanoparticles have applications as potential drugs in the prospective nanomedicine.
纳米技术为抗癌药物的发现提供了替代方法。两亲性纳米载体的核心可以包含疏水性生物活性成分,这导致形成具有改善的生物利用度、促进排泄和降低治疗生物体全身毒性的水分散性产品。本研究旨在形成负载抗癌药物前体鬼臼毒素(PPT)或含PPT的杜松叶提取物的聚合物纳米载体,试图研究它们在A-431表皮样癌细胞和HaCaT正常角质形成细胞中的抗肿瘤活性。两亲性、可生物降解且生物相容的MPEG-PLA二嵌段共聚物在水性介质中自组装成纳米颗粒,通过动态光散射、透射电子显微镜和其他方法研究其物理化学特性。测定了负载PPT成分的胶束具有高包封率。通过彗星试验、流式细胞术、Hoechst DNA染色、Laurdan广义极化和其他方法分析了负载纳米载体在A-431或HaCaT细胞中诱导的DNA片段化、细胞周期停滞、核浓缩、膜脂质有序性评估、活性氧和细胞凋亡。由于负载PPT成分的纳米颗粒诱导的各种细胞过程,与正常细胞相比,效应半胱天冬酶-3和半胱天冬酶-7的激活对肿瘤细胞具有选择性。新获得的含PPT纳米颗粒在未来的纳米医学中作为潜在药物具有应用价值。